Market penetration Strong traction with NFL teams (20+% of league represented) indicates a validated B2B sales path in high-profile sports organizations. Opportunity to scale through league-wide contracts, sponsorship deals, or preferred vendor programs with sports franchises, athletic departments, and professional teams.

Growth capital need The company is seeking growth capital to modernize manufacturing and scale production. This creates an open door for strategic investors or lenders who can facilitate supply chain enhancements, capacity expansion, and faster fulfillment to meet rising demand from sports teams and retailers.

FDA approval path Aiming to expand market share by pursuing FDA approval suggests a potential collaboration point with regulatory consultants, contract manufacturers, and distributors. This opens opportunities to position ourselves as a partner for compliant product development and accelerated time-to-market.

Product expansion Plans to prototype a second product, Ball & Chamber, signal cross-sell and upsell opportunities within injury prevention and performance wear. Sales outreach can target existing customers with bundled offerings and early access to new protective or recovery-oriented apparel.

Digital & D2C potential Current tech stack includes WordPress, WooCommerce, Shopify, and email marketing tools, indicating readiness for direct-to-consumer channels alongside B2B sales. Potential to optimize e-commerce, omnichannel distribution, and B2B storefronts to broaden reach beyond NFL teams to schools, clinics, and fitness organizations.